CVS Health plans to split its retail pharmacy business from its insurance and pharmacy-benefit operations
CVS Health said Wednesday it plans to separate its retail pharmacy business from its insurance and pharmacy-benefit operations, making its drugstores a standalone company called CVS Pharmacy. The Wall Street Journal reported the breakup is planned for the first half of 2028. Aetna and Caremark would remain together, according to NAI 500, reversing the 2018 combination that helped build CVS’s integrated healthcare business.
More context
CVS Health said Wednesday it plans to split its retail pharmacy business from its insurance and pharmacy-benefit operations, breaking up a healthcare company built through years of expansion. The drugstore business is expected to become a separate company called CVS Pharmacy, according to Stocktitan.net. The Wall Street Journal reported the separation is scheduled for the first half of 2028. CVS’s insurance business includes Aetna, while Caremark is its pharmacy-benefit manager; NAI 500 had reported that both would remain together in the other entity. The plan reverses the integrated model built through CVS’s acquisitions, including its purchase of Aetna in 2018. The proposed breakup comes as pharmacy benefit managers face political and regulatory scrutiny over their role in the drug supply chain.
Was this story useful?
What was the main problem? (optional)
Reporting
- Reuters — CVS will split up its pharmacy and insurance business into two companies, WSJ says | Reuters
- Reuters — How CVS built a healthcare empire it now plans to split
- The Wall Street Journal — CVS Will Break Off Its Namesake Pharmacies - WSJ
- nai500.com — CVS Health Reportedly Plans to Split into Two Independent Entities as Business Restructuring Rumors Materialize | NAI 500
- stocktitan.net — CVS Plans to Split Into Two Companies in 2028
Verifier’s note
The Wall Street Journal reported the planned split, and Reuters and StockTitan subsequently reported CVS’s announcement that it would separate its retail pharmacy business from its insurance and pharmacy-benefit operations. NAI 500 and Reuters’ earlier report also describe the planned breakup, consistent with the central claim.